AI & Medicine: Shaping the Future of Health Forum
会议/讲座
摘要
AI has emerged as a powerful tool in medicine, offering unprecedented opportunities to enhance patient care, streamline clinical processes, and drive innovative research. We are thrilled to invite you to the upcoming AI & Medicine: Shaping the Future of Health Forum. The event will feature Guest of Honour and keynote speaker Prof. Barry MARSHALL, 2005 Nobel Laureate in Physiology or Medicine. Joining him in the forum discussion will be Guest of Honour Prof. Ya-Qin ZHANG, Dean of Institute for AI Industry Research & Chair Professor of AI Science, Tsinghua University, to discuss this exciting topic. Details are as follows:
Date: |
21 March 2025 (Friday) |
Time: |
10.30 am - 12.30 pm (Reception starts at 10 am) |
Venue: |
Silverbox Ballroom, 1/F, Hotel ICON |
Keynote Speaker: |
Prof. Barry MARSHALL |
Panellist: |
Prof. Ya-Qin ZHANG |
Moderator: |
Prof. Hongxia YANG |
Language: |
English |
Seats are limited and available on a first-come, first-served basis.
Event Rundown:
10.00 am |
Reception starts |
10.30 am |
Opening Remarks |
10.35 am |
Introduction of Keynote Speaker |
10.40 am |
Keynote Speech: |
11.30 am |
Opening Ceremony of PolyU Marshall Research Centre for Medical Microbial Biotechnology presented by Prof. Raymond WONG, |
11.40 am |
Forum Discussion |
12.10 pm |
Closing Remarks |
讲者
Prof. Barry MARSHALL
2005 Nobel Laureate in Physiology or Medicine
Prof. Barry J. Marshall AC, FRACP, FRS, FAA is an Australian physician and microbiologist best known for his discovery of Helicobacter pylori (H. pylori) and its role in gastric diseases, including peptic ulcers and gastric cancer. In the early 1980s, alongside Robin Warren, he challenged the prevailing belief that ulcers were caused by stress and lifestyle, proving instead that Helicobacter pylori (H. pylori) infection was the primary culprit. To demonstrate his theory, Marshall famously drank a culture of Helicobacter pylori (H. pylori), developed gastritis, and successfully cured himself with antibiotics. This groundbreaking discovery revolutionized gastroenterology and led to effective treatments, benefiting millions worldwide. In 2005, he and Warren were awarded the Nobel Prize in Physiology or Medicine for their pioneering work. As a Professor of Clinical Microbiology, Marshall continues to research innovative diagnostic tools and treatments, particularly in the fight against antibiotic resistance. His work has significantly impacted global healthcare, particularly in high-prevalence regions like East Asia, reducing the burden of gastric ulcers and gastric cancer. A fellow of the Royal Society (FRS) and other prestigious institutions, Marshall remains at the forefront of infectious disease research, advancing new approaches to improve gastrointestinal health worldwide.
你可能也感兴趣